(Reuters) – U.S. Justice Department is preparing to charge Teva Pharmaceutical Industries Ltd with conspiring with competitors to raise prices for generic drugs, Bloomberg Law reported on Tuesday citing a person familiar with the matter.
The decision follows Teva’s refusal to agree for a settlement that would have required paying a criminal penalty and admitting wrongdoing, the report said. (https://bit.ly/32qtltO)
The company declined to comment on the report.
(Reporting By Mrinalika Roy in Bengaluru; Editing by Vinay Dwivedi)
